All Type of News
Hanmi Pharm registers International Nonproprietary Name for its new immune disorder treatment
Hanmi Pharm(CEO Gwan-Sun Lee) decided a name of the self-developed new drug ‘HM71224’ for the treatment of immune system disorder on ‘Poseltinib.’
Hanmi Pharm announced on the 7th ‘Poseltinib’ was recently registered...
No place for drug rebates, it is not ‘option’ but ‘must-follow’ for pharmas
Rebates incidents, which have depressed pharmaceutical companies every time they occur, have become an old word. Although some pharmaceutical companies are still being investigated for rebate and there is a word that ...
Patients society urges health insurance benefits for terminal lung cancer therapy
On the 6th, the Korea Alliance of Patients Organization(hereinafter referring to KAPO) announced a statement to urge prompt application of the health insurance benefits for terminal lung cancer therapies.
The Health ...
Huons accelerates Phase 2 clinical trials for new dry eye biologic in U.S.
Huons Co. Ltd., a holding company of Huons Global Co. Ltd., announced on the 6th that it signed agreements with sample manufacturing companies and contract service organizations for clinical trials to accelerate the c...
Distribution companies required to get consent forms to use personnel information
It was criticized pharmaceutical distribution companies need to be cautious since they might provide information against the Personnel Information Protection Law when providing information about drug sales to pharmace...
New KPMA Chairman’s Quick movements
While its chairmen, executives and employees attended the inauguration of the 21st Korea Pharmaceutical Manufacturers Association(KPMA) Chairman on the last 2nd, Hee-Mok Won, the new chairman who started the 2-year te...
Bloody competition among bioequivalence test service organizations causes shutdown of business
Due to fierce competition among service organizations for bioequivalence test, one of them decided to shut down business.
Korea Pharmaceutical Test & Research Institute, an agency of the Korea Pharmaceutical Traders ...
What are reasons why there have been a drought in new drug approval?
It seems it would be hard new drug developed by Korean pharmaceutical company to be commercialized this year, again.
The Ministry of Food and Drug Safety anticipated 1 Korean new drug will acquire approval this year....
Biowood will target infertility market with Korea’s first and only private sperm bankOn the last 28th of February, Biowood(CEO Sung-Hoon Ahn), a subsidiary of Kemimedi(CEO Gun-Seop Choi), a company specializing in developing new drugs for treatment of rare and i...
|
Will distribution industry’s suggestions be reflected to enforcement of serial number system?
Even though enforcement of the serial number system for pharmaceutical distribution companies has created issues, it will still be implemented this July. Thus, the industry has paid attention to whether the government...
